![David Bejker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bejker
Direttore/Membro del Consiglio presso
ABLIVA AB
Profilo
David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
Mr. Bejker is an Independent Director at Abliva AB since 2017.
Mr. Bejker is a Director at Amylonix AB. Mr. Bejker is a Director at Disruptive Pharma Holding AB. Mr. Bejker is an Independent Non-Executive Director at Disruptive Pharma AB since 2023.
Former positions include Chief Executive Officer & Director at Affibody AB from 2003 to 2005, Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduation from Stockholm School of Economics.
Posizioni attive di David Bejker
| Società | Posizione | Inizio |
|---|---|---|
| ABLIVA AB | Direttore/Membro del Consiglio | 27/04/2017 |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Amministratore Delegato | 01/12/2018 |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Direttore/Membro del Consiglio | - |
Disruptive Pharma Holding AB | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di David Bejker
| Società | Posizione | Fine |
|---|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Amministratore Delegato | 01/07/2005 |
| LIDDS AB | Direttore/Membro del Consiglio | - |
| NEXSTIM PLC | Corporate Officer/Principal | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Formazione di David Bejker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
 Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Disruptive Pharma Holding AB |
